Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT07502716
Clinical Trial
Compassionate Use of Ubamatamab
Available
View on ClinicalTrials.gov →
Summary
Provide Compassionate Use of Ubamatamab
Trial Details
NCT Number
NCT07502716
Lead Sponsor
Regeneron Pharmaceuticals
Conditions
Renal Medullary Carcinoma (RMC), Epithelioid Sarcoma
Updated on ClinicalTrials.gov
2026-03-31